KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Inventory (2016 - 2025)

Amgen (AMGN) has 17 years of Inventory data on record, last reported at $6.2 billion in Q4 2025.

  • For Q4 2025, Inventory fell 11.05% year-over-year to $6.2 billion; the TTM value through Dec 2025 reached $6.2 billion, down 11.05%, while the annual FY2025 figure was $6.2 billion, 11.05% down from the prior year.
  • Inventory reached $6.2 billion in Q4 2025 per AMGN's latest filing, down from $6.3 billion in the prior quarter.
  • Across five years, Inventory topped out at $9.5 billion in Q4 2023 and bottomed at $4.0 billion in Q1 2021.
  • Average Inventory over 5 years is $5.8 billion, with a median of $5.0 billion recorded in 2023.
  • Peak YoY movement for Inventory: skyrocketed 93.06% in 2023, then decreased 26.48% in 2024.
  • A 5-year view of Inventory shows it stood at $4.1 billion in 2021, then rose by 20.66% to $4.9 billion in 2022, then surged by 93.06% to $9.5 billion in 2023, then fell by 26.48% to $7.0 billion in 2024, then decreased by 11.05% to $6.2 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Inventory were $6.2 billion in Q4 2025, $6.3 billion in Q3 2025, and $6.6 billion in Q2 2025.